Skip to main content

Table 3 The impact of HER2-low expression on breast cancer-specific survival

From: Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society

  Breast cancer-specific survival
Before IPTW After IPTW
HRs (95% CI) P value HRs (95% CI) P value
Hormone receptor-positive 0.72 (0.44–1.17) .188 0.72 (0.44–1.17) .187
Hormone receptor-negative 0.64 (0.38–1.09) .098 0.61 (0.35–1.05) .075